# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-130728
Filing Date
2023-05-01
Accepted
2023-05-01 17:20:59
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | d480900ddefa14a.htm | DEFA14A | 11147
2 | GRAPHIC | g480900g01p37.jpg | GRAPHIC | 374766
3 | GRAPHIC | g480900g01p38.jpg | GRAPHIC | 270609
| Complete submission text file | 0001193125-23-130728.txt |  | 901470

Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14027 | Film No.: 23875211
SIC: 3841 Surgical & Medical Instruments & Apparatus